Day: August 27, 2024

Šiaulių Bankas AB plans a Senior Preferred note offering, subject to market conditions

Written by Customer Service on August 27, 2024. Posted in Public Companies.

THIS NOTICE CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) No 596/2014 (“MAR”). THIS NOTICE DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER, INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF AKCINĖ BENDROVĖ ŠIAULIŲ BANKAS. On 27 August 2024, the Management Board of Šiaulių Bankas AB approved a potential benchmark-size Senior Preferred note offering which would follow subject to market conditions. Šiaulių Bankas AB has mandated Citigroup, Erste Group, Goldman Sachs Bank Europe SE, Morgan Stanley and Šiaulių Bankas AB as Joint Lead Managers to arrange a series of virtual fixed income investor meetings commencing on 27th August. Relevant stabilisation regulations including FCA/ICMA will apply. This communication is not an offer...

Oculis Reports Q2 2024 Financial Results and Provides Recent Company Update

Written by Customer Service on August 27, 2024. Posted in Earnings Releases And Operating Results.

Reported positive topline results for the Phase 2b RELIEF trial of OCS-02 (licaminlimab) paving the way for potentially the first precision medicine in Dry Eye Disease (DED) Phase 2 ACUITY trial of OCS-05 in acute optic neuritis (AON) is on track for topline readout in Q4 2024 Pre-NDA meeting with U.S. Food and Drug Administration (FDA) completed in August for once daily OCS-01 for the treatment of post-operative inflammation and pain following ocular surgery; Providing a clear path forward for NDA submission in Q1 2025, while randomization in Phase 3 DIAMOND-1 and DIAMOND-2 trials in diabetic macular edema (DME) is on track Cash, cash equivalents and short-term investments of $131.2 million as of June 30, 2024 provides cash runway into the 2H 2026.ZUG, Switzerland, Aug. 27, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq:...

Oculis Reports Q2 Financial Results and Provides Recent Company Update

Written by Customer Service on August 27, 2024. Posted in Earnings Releases And Operating Results.

ZUG, Switzerland, Aug. 27, 2024 (GLOBE NEWSWIRE) — Reported positive topline results for the Phase 2b RELIEF trial of OCS-02 (licaminlimab) paving the way for potentially the first precision medicine in Dry Eye Disease (DED) Phase 2 ACUITY trial of OCS-05 in acute optic neuritis (AON) is on track for topline readout in Q4 2024 Pre-NDA meeting with U.S. Food and Drug Administration (FDA) completed in August for once daily OCS-01 for the treatment of post-operative inflammation and pain following ocular surgery; Providing a clear path forward for NDA submission in Q1 2025, while randomization in Phase 3 DIAMOND-1 and DIAMOND-2 trials in diabetic macular edema (DME) is on track Cash, cash equivalents and short-term investments of $131.2 million as of June 30, 2024 provides cash runway into the 2H 2026.Oculis Holding AG (Nasdaq:...

Correction: NNIT A/S: SOLID ORGANIC GROWTH OF 11%, PROFITABILITY CONTINUED TO IMPROVE, AND IMPORTANT STRATEGIC MILESTONES REACHED

Written by Customer Service on August 27, 2024. Posted in Earnings Releases And Operating Results.

Correction: The two metrics “Earnings per share” and “Diluted earnings per share” were incorrectly stated for 6M 2024 in the Q2 2024 interim financial report, company announcement 05/2024. The correct “Earnings per share” is DKK 1.41 and “Diluted earnings per share” is DKK 1.41 as of 30th June 2024. An updated version of the interim financial report is attached. Q2 2024 key highlightsFinancial performance continued to improve during the second quarter with organic growth at 11.0% meaning NNIT is capturing market share, specifically in Denmark and Europe. Growth was seen across all regions, with the exception of Region US, which continued to be negatively impacted by the temporary decline in the data migration business, despite gradual improvements. Group operating profit margin excluding special items ended at 6.7%, which is an 0.8%-point...

Nokia selected by Claro Argentina for 5G network deployment

Written by Customer Service on August 27, 2024. Posted in Public Companies.

Press ReleaseNokia selected by Claro Argentina for 5G network deploymentNokia to provide equipment from its industry-leading AirScale portfolio, including services. 5G to underpin digital revolution across Argentina supporting vertical sectors, including manufacturing, and oil and gas. Claro Argentina first customer to deploy Nokia’s Interleaved Passive Active Antenna (IPAA+) across its entire site footprint.27 August 2024 Espoo, Finland – Nokia today announced it has signed a comprehensive 5G deal with Claro Argentina (Claro) to deploy 5G infrastructure across the country. The agreement will cover the first phase of 5G implementation in the country, reaching Argentina’s largest cities. The deal supports Claro’s strategy of digitizing Argentina with reliable, low-latency and ultra-high-speed connectivity for consumers and enterprises....

Financial Calendar 2024/25

Written by Customer Service on August 27, 2024. Posted in Public Companies.

Financial Calendar 2024/25 17 September 2024, Annual Report 2023/24 22 October 2024, Annual General Meeting in Rovsing A/S 12 November 2024, Interim Management Statement Q1 2024/25 20 February 2025, Interim Report for H1 2024/25 13 May 2025, Interim Management Statement for Q3 2024/25 16 September 2025, Annual Report 2024/25 21 October 2025, Annual General Meeting in Rovsing A/S Further information: Sigurd Hundrup, CFO. Tel. +45 53 39 18 92. Email: shu@rovsing.dkAttachmentAnnouncement367_Financial Calendar 2024-25

Notice on Concluded Hotel Management Agreement

Written by Customer Service on August 27, 2024. Posted in Public Companies.

UAB “Orkela,” legal entity code 304099538, registered address at Jogailos St. 4, Vilnius, Republic of Lithuania (the Issuer), whose securities (the Bonds) are listed and admitted to trading on the Bond List of Nasdaq, also the Bonds are being publicly offered under the base prospectus approved by the Bank of Lithuania on 14 November 2023 (the Prospectus). The Issuer wishes to inform you that its affiliated entity, UAB “Pakeira,” has entered into a Hotel Management Agreement with Apex Alliance Hotel Management, UAB (legal entity code 304231032, registered address: Šeimyniškių g. 19-301, Vilnius, Republic of Lithuania). Pursuant to this Hotel Management Agreement, Apex Alliance Hotel Management, UAB will assume management responsibilities for the AC Hotel by Marriott located within the building complex developed at Vasario 16...

Valeura Energy Inc.: Nong Yao C Production Ramp Up

Written by Customer Service on August 27, 2024. Posted in Public Companies.

SINGAPORE, Aug. 27, 2024 (GLOBE NEWSWIRE) — Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) is pleased to announce the successful ramp-up of oil production at its Nong Yao C development, in Licence G11/48 , offshore Gulf of Thailand. The greater Nong Yao complex is now operating at its full processing capacity, with stable average production over the past seven days of 13.4 mbbls/d (12.1 mbbls/d net to the Company’s 90% working interest share, before royalties). This production, when combined with the Wassana field being back online has resulted in stable aggregate oil production over the past week of 26.2 mbbls/d (Company’s working interest share, before royalties). Dr. Sean Guest, President and CEO commented: “I am very pleased to see the Nong Yao complex operating...

Notice on the terms of the reorganisation of INVL Baltic Real Estate and AB Pramogų bankas

Written by Customer Service on August 27, 2024. Posted in Public Companies.

In accordance with Article 65(1) of the Republic of Lithuania Law on Companies, we hereby notify of the terms of the reorganisation of the special closed-end real estate investment company INVL Baltic Real Estate (hereinafter – INVL Baltic Real Estate), code: 152105644, registered office address: Vilnius, Gynėjų g. 14 and the joint stock company Pramogų bankas (hereinafter – AB Pramogų bankas), code: 300044665, registered office address: Vilnius, A. Stulginskio str. 8, on the basis of which AB Pramogų bankas is merged with INVL Baltic Real Estate, that is continuing operations and which owns 100% of the shares of AB Pramogų bankas (the provisions of Article 70 of the Republic of Lithuania Law on Companies are applied to the merger). The reorganisation period will continue until a new version of the Articles of Association of INVL Baltic...

Green Hydrogen Systems – Interim Report for H1 2024

Written by Customer Service on August 27, 2024. Posted in Earnings Releases And Operating Results.

Company Announcement August 2024 Green Hydrogen Systems – Interim Report for H1 2024 Business highlightsIn the first half of 2024, total revenue, including service revenue, reached DKK 32.6 million. H1 2023 total revenue was DKK 14.0 million. In H1 2024, six electrolyser units passed factory acceptance test and were delivered at customer sites in Sweden, Germany, The Netherlands, and the United Kingdom. In addition, two electrolyser units have passed factory acceptance test after H1 and await shipment to customer sites. Firm order intake for nine A-Series units totaled 8.1 MW in the first half of 2024 with delivery scheduled for H2 2024 and into H1 2025. The total order backlog by end-June 2024 was 15.0 MW. The Company has identified a total of 550 MW of priority 1 larger scale hydrogen-related production projects in development. However,...

Day: August 27, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice